• The Journal of the Acoustical Society of Korea
• /
• v.24 no.7
• /
• pp.379-386
• /
• 2005

Among various kinds of hearing aids which have been developed so far. the conventional air conduction hearing aids have some problems such as the acoustic distortion, an howling effect due to acoustic feedback. Another type of hearing aid. the cochlear implant system can be applied to the profound imparied person. However. it shows the disadvantage that there is no possibility of recovery of the acoustic organ such as ossicle. On the other hand. the implantable middle ear heaving device directly vibratos the ossicular chain and has better sound qualify. good cosmetics for appearance. and wide frequency responses so that it can overcome the defects or the conventional hearing aids. In this paper, a mathematical modeling and a momentum equation derivation of the DET has been performed. For the optimization of the structure dimension generating maximal vibrating force of the DET. the computer simulation using a finite element analysis (FEA) software has been performed. Also. the vibrating transducer has been designed to make the frequency characteristics or the transducer be similar to those of the normal middle ear. Through the experimental results, the measured vibration characteristics of the DET has been evaluated to verify the performance for the application to implantable middle ear hearing devices.

• Archives of Plastic Surgery
• /
• v.46 no.6
• /
• pp.594-598
• /
• 2019

Overall complication rates of 9.1% have been reported following implantable cardioverter defibrillator (ICD) placement. Brachial plexus injury is infrequently reported in the literature. We describe a 26-year-old female experiencing left arm nerve pain, a positive Tinel's sign, numbness in the median nerve distribution of the hand and biceps muscle weakness following revision ICD via subclavian vein approach. Nerve conduction studies identified severe partial left brachial plexopathy, which remained incompletely resolved with conservative management. Surgical exploration revealed lateral cord impingement by the ICD generator and a loop of the ICD lead, along with fibrosis, necessitating surgical neurolysis and ICD generator repositioning. As increasing numbers of patients undergo cardiac device implantation, it is incumbent on practitioners to be aware of potential increases in the prevalence of this complication.

• Progress in Medical Physics
• /
• v.16 no.3
• /
• pp.155-159
• /
• 2005

As a part of implantable device in body, a transcutaneous energy transmission system has been developed. It would be desirable to tansfer electrical energy to implantable devices transcutaneously. The distance between transcutaneous transformer windings are approximately equal to the thickness of the human's skin, nominally between 10$\~$20 mm. Class-E resonant amplifier is used to drive a primary coil for high efficiency. Maximum current is above 50 mA at any frequency. The developed system shows that the circuit operates correctly at each frequency; 500 kHz, 1 MHz and 4 MHz.

• Proceedings of the KOSOMBE Conference
• /
• v.1996 no.05
• /
• pp.243-247
• /
• 1996

Electro-magnetic type implantable middle ear hearing aid has been empirically developed. But for further improvement of the system performance more quantitative approach is necessary. In this paper, we analyzed vibrating transducer which is most important to design the system, appropriate for given hearing level, and implemented it. Using this transducer, implantable hearing aid system are developed. To verify the design process, we experimented with driving metal strip by the developed system. From the experiment, frequency response of implemented device showed good characteristic at audio frequency and we confirmed that each part of the developed system operated well.

• Journal of Digital Convergence
• /
• v.10 no.2
• /
• pp.141-146
• /
• 2012

U-healthcare, which grafted advanced IT technology onto medical technology, is in the limelight because it can provide medical services at anytime and anywhere. U-healthcare system applied RFID technology for Implantable Medical Device (IMD), but patient's biometric information can be easily exposed to third parties. In this article, RFID-based U-healthcare authentication protocol is proposed to prevent illegal usage for personal biometric information exposed to the third patty. The proposed protocol guarantees patients' biometric information integrity as compounding random numbers between administrators and hospital/clinic managers, and uses continuous number SEQ and time stamp T to synchronize IMD/administrators and administrators/hospital managers. Also, to protect user's privacy from the third party, patients' biometric information can be safely guarded by managing patients' security identifiers by administrators.

• Archives of Plastic Surgery
• /
• v.44 no.1
• /
• pp.34-41
• /
• 2017

Background The current indications of cardiac implantable electronic devices (CIEDs) have expanded to include young patients with serious cardiac risk factors, but CIED placement has the disadvantage of involving unsightly scarring and bulging of the chest wall. A collaborative team of cardiologists and plastic surgeons developed a technique for the subpectoral placement of CIEDs in young female patients via a transaxillary approach. Methods From July 2012 to December 2015, subpectoral CIED placement via an axillary incision was performed in 10 young female patients, with a mean age of 25.9 years and mean body mass index of $20.1kg/m^2$. In the supine position, with the patient's shoulder abducted, an approximately 5-cm linear incision was made along one of the deepest axillary creases. The submuscular plane was identified at the lateral border of the pectoralis major, and the dissection continued over the clavipectoral fascia until the subpectoral pocket could securely receive a pulse generator. Slight upward dissection also exposed an entrance to the subclavian vein, allowing the cardiology team to gain access to the vein. One patient with dilated cardiomyopathy underwent augmentation mammoplasty and CIED insertion simultaneously. Results One case of late-onset device infection occurred. All patients were highly satisfied with the results and reported that they would recommend the procedure to others. Conclusions With superior aesthetic outcomes compared to conventional methods, the subpectoral placement of CIEDs via a transaxillary approach is an effective, single-incision method to hide operative scarring and minimize bulging of the device, and is particularly beneficial for young female or lean patients.

• Clinical and Experimental Pediatrics
• /
• v.49 no.9
• /
• pp.930-936
• /
• 2006

Although antiarrhythmic medication has been the main treatment modality for arrhythmia in children, in recent decades technological development and computerization have made great advances in nonpharmacological therapy. This article reviews the transcatheter radiofrequency ablation for tachycardia in children, recent advances of device therapy for bradycardia, antitachycardia pacing, implantable cardioverter defibrillator. As a new field of device therapy, cardiac resynchronization therapy for congestive heart failure is also mentioned.

• Journal of Sensor Science and Technology
• /
• v.27 no.2
• /
• pp.99-104
• /
• 2018

A micro electromagnetic actuator with high vibration efficiency is proposed for use in an implantable hearing device. The actuator, which can be implanted in the middle ear, consists of membranes based on the stainless steel 304 (SUS-304), and other components. In conventional actuators, in which a thick membrane and a silicone elastomer are used, the size reduction was difficult. In order to miniaturize the size of the actuator, it is necessary to reduce the size of the actuation potion that generates the driving force, resulting in reduction of the electromagnetic force. In this paper, the electromagnetic actuator is further miniaturized by the metal membrane and the vibration amplitude is also optimized. The actuator designed according to the simulation results was fabricated by using micro-electro-mechanical systems (MEMS) technology. In particular, a $20{\mu}m$ thick metal membrane was fabricated using the erosion process, which reduced the length of the actuator by more than $400{\mu}m$. In the experiments, the vibration displacement characteristics of the optimized actuator were above 400 nm within the range of 0.1 to 1 kHz when a current of $1mA_{rms}$ was applied to the coil.

• Journal of Korean Biological Nursing Science
• /
• v.23 no.4
• /
• pp.298-307
• /
• 2021

Purpose: This study aimed to investigate the risk factors for cardiac implantable electronic device (CIED)-related infections within the first post-procedural year after CIED insertion. Methods: This study included 509 adult patients undergoing CIED implantation procedures between January 1, 2011 and December 31, 2015. The data were analyzed by t-test, chi-square test, Fisher's exact test, and logistic regression analysis using SPSS/WIN 23.0. Results: Fifteen infections and 494 non-infections were examined. The CIED-related infection rate was 2.9%; patients with 14 pocket infections and one bacteremia were included in the CIED-related infection. The risk factors of CIED-related infections were the estimated glomerular filtration rate (eGFR) of ≤ 45 mL/min/1.73 m² (Odds ratio [OR]= 4.03, 95% confidence interval [CI],1.15-14.10) and taking a new oral anticoagulant (NOAC) (OR = 4.50, 95% CI 1.09-18.55). Conclusion: These results identified the CIED infection rate and risk factors of CIED-related infection. It is necessary to consider these risk factors before the CIED implantation procedure and to establish the relevant nursing interventions.

• Journal of the Institute of Electronics Engineers of Korea SC
• /
• v.48 no.5
• /
• pp.74-80
• /
• 2011

Medical implant devices are one of the targets of the US's Food & Drug Administration (FDA) for tracking in case of a serious adverse event since they are directly connected to the lives of patients. The US law stipulates that the public health agency shall order implantable device makers to track their product down to the patient level if a serious adverse event has occurred or defects have been discovered; in reality, however, the agency can pass on the responsibility for tracking or recalling faulty devices to the manufacturers or use mass media. This article proposes an efficient tracking and recall management system and examines four main virtual scenarios based on such. This research seeks to suggest a system that enables FDA to perform accurate and prompt tracking and recall management for patients' enhanced safety.